The report "Medical Elastomers Market by Type (Thermoset and Thermoplastic), Application (Medical Tubes, Catheters, Syringes, Gloves, Medical Bags, and Implants), and Region (North America, Europe, APAC, MEA, and South America) Global Forecast to 2022" The medical elastomers market is projected to reach USD 7.92 Billion by 2022, at a CAGR of 7.5% between 2017 and 2022. The medical elastomers market is projected to grow from USD 5.51 Billion in 2017 to USD 7.92 Billion by 2022, at a CAGR of 7.5% from 2017 to 2022. The growth of the market is attributed to rising demand for medical devices across the globe. Increased awareness among governments to provide high-quality healthcare infrastructure is also expected to drive the market for medical devices. This will, in turn, grow the medical elastomers market across the globe.
The APAC region is the fastest-growing market for medical elastomers across the globe. The growth of the APAC medical elastomers market can be attributed to the growing population and increasing healthcare expenditure of countries in this region. In APAC, the demand for medical elastomers is majorly driven by emerging economies, such as Indonesia, Japan, China, and India. The increased use of single-use medical devices, such as catheters, medical tubes, gloves, and syringes, is also expected to drive the growth of the APAC medical elastomers market during the forecast period.
BASF SE (Germany), DowDuPont (US), Eastman Chemical Company (US), Royal DSM (Netherlands), Solvay S.A. (Belgium), Trelleborg AB (Sweden), Momentive Performance Materials Inc. (US), Celanese Corporation (US), PolyOne Corporation (US), Teknor Apex (US), and Kuraray Co. Ltd. (Japan) are some of the leading players operating in the medical elastomers market.
